Journey Medical (DERM) Cash from Operations (2020 - 2026)

Journey Medical has reported Cash from Operations for 7 years, with the latest figure at 2909000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 202.72% year-over-year to 2909000.0; the trailing twelve-month figure through Mar 2026 stood at 6700000.0 (up 3.46% YoY), and the FY2025 full-year result was 12441000.0, down 36.31% from the prior year.
• Cash from Operations for Q1 2026 stood at 2909000.0, up from 6284000.0 in the prior quarter.
• The five-year high for Cash from Operations was 18747000.0 in Q3 2023, with the low at 16520000.0 in Q4 2023.
• Historically, Cash from Operations has averaged 1585470.59 across 5 years, with a median of 2383000.0 in 2025.
• Annual changes were most pronounced in 2023 — Cash from Operations soared 357.44% — and 2024, when it tumbled 425.0%.
• Journey Medical's Cash from Operations stood at 3836000.0 in 2022, then slumped by 330.66% to 16520000.0 in 2023, then soared by 113.47% to 2225000.0 in 2024, then slumped by 382.43% to 6284000.0 in 2025, then surged by 146.29% to 2909000.0 in 2026.
• The last three Cash from Operations figures came in at 2909000.0 (Q1 2026), 6284000.0 (Q4 2025), and 2383000.0 (Q3 2025), per Business Quant data.